De Lisle Partners LLP increased its stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 6.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 407,801 shares of the company's stock after purchasing an additional 26,339 shares during the period. The Pennant Group makes up 1.7% of De Lisle Partners LLP's holdings, making the stock its 11th largest position. De Lisle Partners LLP owned approximately 1.17% of The Pennant Group worth $10,260,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in PNTG. KLP Kapitalforvaltning AS acquired a new position in The Pennant Group in the 4th quarter worth $188,000. LPL Financial LLC acquired a new position in shares of The Pennant Group during the 4th quarter worth about $225,000. Vanguard Group Inc. boosted its stake in shares of The Pennant Group by 11.0% during the 4th quarter. Vanguard Group Inc. now owns 2,261,564 shares of the company's stock worth $59,977,000 after buying an additional 223,919 shares during the last quarter. Corebridge Financial Inc. boosted its stake in shares of The Pennant Group by 6.2% during the 4th quarter. Corebridge Financial Inc. now owns 16,227 shares of the company's stock worth $430,000 after buying an additional 954 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of The Pennant Group by 16.0% during the 4th quarter. Wellington Management Group LLP now owns 48,853 shares of the company's stock worth $1,296,000 after buying an additional 6,753 shares during the last quarter. 85.88% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Stephens restated an "overweight" rating and set a $35.00 price objective on shares of The Pennant Group in a research note on Tuesday, June 10th. Wells Fargo & Company increased their price objective on shares of The Pennant Group from $30.00 to $31.00 and gave the stock an "equal weight" rating in a research note on Tuesday, June 3rd. Finally, Truist Financial reduced their price objective on shares of The Pennant Group from $32.00 to $28.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $33.80.
View Our Latest Stock Analysis on The Pennant Group
The Pennant Group Trading Down 0.6%
Shares of NASDAQ:PNTG opened at $23.22 on Tuesday. The Pennant Group, Inc. has a 52-week low of $21.18 and a 52-week high of $37.13. The company has a market capitalization of $800.39 million, a P/E ratio of 30.55, a price-to-earnings-growth ratio of 1.98 and a beta of 1.51. The company has a 50-day simple moving average of $27.01 and a 200 day simple moving average of $26.27. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.41 and a current ratio of 1.41.
Insider Transactions at The Pennant Group
In related news, Director Joanne Stringfield sold 5,000 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the sale, the director directly owned 30,275 shares in the company, valued at approximately $892,204.25. This trade represents a 14.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 5.40% of the company's stock.
The Pennant Group Company Profile
(
Free Report)
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.